BIO-key International has approved a 1-for-18 reverse stock split that will become effective with the commencement of trading on December 21, 2023.BIO-key stockholders approved a proposal last week to allow the Board to proceed with a reverse split to assist the Company in its effort to regain compliance with the minimum bid price requirement. BIO-key had approximately 16.9 million shares of common stock issued and outstanding as of December 19, 2023. After giving effect to the 1-for-18 reverse stock split, BIO-key will have approximately 941,000 shares of common stock issued and outstanding.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BKYI:
- Following Stockholder Approval, BIO-key Announces 1-for-18 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Price Requirement
- Genesis HealthCare to add BIO-key’s PortalGuard IAM platform
- Genesis HealthCare System Builds on its Investment in BIO-key Biometric Authentication Security as it Migrates to Epic Hyperdrive
- BIO-key enters partnership with Ping Identity
- BIO-key showcases authentication innovations Boston Cyber Security Summit